DONGSUNG PHARMACEUTICAL CO.,LTD Q3 operating loss of KRW 1.7 billion, turning to a loss; sales KRW 19.8 billion
AI summary · Not investment advice
In the third quarter, the company sold KRW 19.8 billion worth of goods and lost KRW 1.7 billion from its main business, down from a profit a year earlier.
Operating profit · 3 months
KRW -1.7 billion
Key facts
- Revenue (3 months)
- KRW 19.8 billion
- Net income (3 months)
- KRW -28.0 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 21.8 billion
- Revenue (year to date)
- KRW 61.0 billion
- Operating profit (prior-year 3 months)
- KRW 411.1 million
- Operating profit (year to date)
- KRW -3.5 billion
- Net income (prior-year 3 months)
- KRW 112.3 million
- Net income (year to date)
- KRW -33.9 billion
Commentary
AI commentary · Not investment advice
What happened
Dongsung Pharmaceutical filed its quarterly report for the 3rd quarter of 2026 on a standalone basis. Sales for the latest 3 months were KRW 19.82 billion. That is 9.1% lower than the same 3 months a year earlier (KRW 21.80 billion). It is also 10.3% lower than the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was a loss of KRW 1.73 billion. A year earlier it was a profit of KRW 411.4 million. It turned from profit to loss.
What changes for shareholders
Net income (the final profit after all costs and taxes) for the 3 months was a loss of KRW 27.97 billion. A year earlier it was a profit of KRW 112.3 million. It also turned from profit to loss.
For the year to date (Jan 1 to Sep 30), sales were KRW 61.03 billion. Operating profit was a loss of KRW 3.47 billion. Net income was a loss of KRW 33.85 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
D